Emisphere Reports Additional Clinical Data From Phase 2 Oral Insulin Trial Medical News Today
Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS) announced today additional results from its 90-day, Phase 2 study of its oral insulin product utilizing the Company's eligen(R) oral delivery technology. [click link for full article]
NPS Pharmaceuticals Reports Third Quarter and Nine Month Results FinanzNachrichten
PARSIPPANY, N.J., Nov. 8 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, ( Nachrichten ) Inc. today reviewed recent corporate developments, reported its operating and financial results for the three and nine months ended September 30, 2006, and reiterated its previous financial guidance.
NPS Pharmaceuticals Reports Third Quarter and Nine Month Results PR Newswire via Yahoo! Finance
NPS Pharmaceuticals, Inc. today reviewed recent corporate developments, reported its operating and financial results for the three and nine months ended September 30, 2006, and reiterated its previous financial guidance.
NIAMS Funds New Centers of Research Translation National Institutes of Health
Bridging the gap between bench and bedside is the goal of four new Centers of Research Translation (CORTs) funded by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH).
NICE Recommends Mimpara® cinacalcet For The Treatment Of A Serious Complication Of Kidney Disease, UK Medical News Today
The National Institute for Health and Clinical Excellence (NICE) has released a positive Final Appraisal Document (FAD) in support of the use of Mimpara® (cinacalcet) for the treatment of severe secondary hyperparathyroidism (SHPT), a serious complication of kidney failure, in patients with end stage renal disease (ESRD) on maintenance dialysis therapy. [click link for full article]
Emisphere Technologies, Inc. to Hold Conference Call to Discuss Third Quarter 2006 Financial Results FinanzNachrichten
TARRYTOWN, N.Y., Nov. 6 /PRNewswire-FirstCall/ -- Emisphere Technologies, ( Nachrichten ) Inc. will hold a teleconference to discuss its third quarter 2006 financial results on Thursday, November 9, 2006, beginning at 10:00 a.m. Eastern Time. A replay of the call will be accessible approximately two hours following the end of the call and will be archived through November 16, 2006.
Emisphere Technologies, Inc. Presentation at Rodman & Renshaw 8th Annual Healthcare Conference to be Webcast FinanzNachrichten
TARRYTOWN, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- Emisphere Technologies, ( Nachrichten ) Inc. today announced that it will present at the Rodman&Renshaw 8th Annual Healthcare Conference, taking place on November 6-8, 2006 at the New York Palace Hotel in New York City. Michael M. Goldberg, M.D., Chairman and Chief Executive Officer, will present on Wednesday, November 8, 2006, at 11:40 a.m.
Emisphere Technologies, Inc. Presentation at Rodman & Renshaw 8th Annual Healthcare Conference to be Webcast PR Newswire via Yahoo! Finance
Emisphere Technologies, Inc. today announced that it will present at the Rodman & Renshaw 8th Annual Healthcare Conference, taking place on November 6-8, 2006 at the New York Palace Hotel in New York City.
Nektar Announces Third Quarter 2006 Financial Results Business Wire via Yahoo! Finance
SAN CARLOS, Calif.----Nektar Therapeutics announced today its financial results for the three months ended September 30, 2006.
Nastech Announces Third Quarter 2006 Financial Results FinanzNachrichten
BOTHELL, Wash., Nov. 1 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company ( Nachrichten ) Inc. today reported financial results for the three- and nine-month periods ended September 30, 2006.

Normal Parathyroid Function: How Parathyroid Glands Work, How
Parathyroid glands control blood calcium and bone calcium. Parathyroids function and work by making parathyroid hormone. Parathyroid disease causes
Hypoparathyroidism and too little parathyroid hormone. A
hypoparathyroid disease and hypoparathyroidism. Too little parathyroid hormone. Hypo-parathyroid, low calcium, rocaltrol, calcitriol, hypopara.
parathyroid hormone

Parathyroid Hormone
A parathyroid hormone (PTH) blood test measures the level of parathyroid - hormone - to help diagnose - hyperparathyroidism -
Thyroid and Parathyroid Glands
The thyroid gland also produces another hormone called calcitonin, and the parathyroid glands secrete parathyroid hormone. Parathyroid hormone and

Parathyroid Hormone
A parathyroid hormone (PTH) blood test measures the level of parathyroid - hormone - to help diagnose - hyperparathyroidism -
Hypoparathyroidism and too little parathyroid hormone. A
hypoparathyroid disease and hypoparathyroidism. Too little parathyroid hormone. Hypo-parathyroid, low calcium, rocaltrol, calcitriol, hypopara.
Thyroid and Parathyroid Glands
The thyroid gland also produces another hormone called calcitonin, and the parathyroid glands secrete parathyroid hormone. Parathyroid hormone and
parathyroid hormone - HighBeam Encyclopedia
PARATHYROID HORMONE [parathyroid hormone] or parathormone, a hormone secreted by the parathyroid glands that regulates the metabolism of calcium a.
Recombinant human parathyroid hormone -- Reeve 324 (7335): 435 -- BMJ
The first experiments showing an anabolic effect of parathyroid hormone on bone in young When parathyroid hormone and calcitonin had both been purified,
NEJM -- The Effects of Parathyroid Hormone, Alendronate, or Both
Original Article from The New England Journal of Medicine -- The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis.
NEJM -- The Effects of Parathyroid Hormone and Alendronate Alone
Original Article from The New England Journal of Medicine -- The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal
Parathyroid hormone test
The parathyroid hormone (PTH) test is a blood test performed to determine the serum levels of a hormone secreted by the parathyroid gland in response to low